Comparison of two hyoscyamine 6β-hydroxylases in engineering scopolamine biosynthesis in root cultures of Scopolia lurida.

Author: BaiGe, ChenMin, HuangLuqi, LanXiaozhong, LiaoZhihua, LiuKe, ZengJunlan, ZhangFangyuan

Paper Details 
Original Abstract of the Article :
Scopolia lurida, a medicinal plant native to the Tibetan Plateau, is among the most effective producers of pharmaceutical tropane alkaloids (TAs). The hyoscyamine 6β-hydroxylase genes of Hyoscyamus niger (HnH6H) and S. lurida (SlH6H) were cloned and respectively overexpressed in hairy root cultures ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.bbrc.2018.01.173

データ提供:米国国立医学図書館(NLM)

Engineering Scopolamine Biosynthesis in Root Cultures

The field of [pharmaceutical production] is constantly seeking new ways to optimize the production of valuable medicinal compounds. This study focuses on improving the biosynthesis of scopolamine, a crucial tropane alkaloid, in root cultures of Scopolia lurida. The researchers explore the potential of overexpressing hyoscyamine 6β-hydroxylase genes (H6H) from different plant sources to enhance scopolamine production.

Overexpressing HnH6H Boosts Scopolamine Production

The study reveals that overexpressing HnH6H, the H6H gene from Hyoscyamus niger, resulted in significantly higher scopolamine levels in root cultures compared to overexpressing SlH6H, the gene from S. lurida. This finding suggests that HnH6H is a more effective enzyme for engineering scopolamine production in S. lurida root cultures.

A Step Towards Sustainable Scopolamine Production

This research offers a promising approach to sustainably produce scopolamine, a valuable medicinal compound. By optimizing the biosynthesis of scopolamine in root cultures, this study provides a potential solution for the challenges associated with traditional methods of production. This advancement has the potential to contribute to the development of more efficient and sustainable pharmaceutical production processes.

Dr.Camel's Conclusion

Just as a camel carefully selects the most succulent plants in the desert, researchers are carefully choosing the right tools to optimize the production of valuable medicinal compounds. This research demonstrates the power of genetic engineering to enhance scopolamine biosynthesis, opening up new possibilities for sustainable pharmaceutical production. This is a significant step toward ensuring a reliable and efficient supply of this crucial medicinal compound.

Date :
  1. Date Completed 2018-03-23
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

29407173

DOI: Digital Object Identifier

10.1016/j.bbrc.2018.01.173

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.